Format

Send to

Choose Destination
Lancet Haematol. 2018 Dec;5(12):e600-e601. doi: 10.1016/S2352-3026(18)30193-5.

Intensive immunochemotherapy for high-risk aggressive B-cell lymphomas: MYC-rearrangements and beyond.

Author information

1
Cleveland Clinic Foundation, Cleveland, OH 44195, USA. Electronic address: hsie@ccf.org.

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center